Dentsply SironaXRAY
About: Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).
Employees: 14,000
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
61% more call options, than puts
Call options by funds: $19.9M | Put options by funds: $12.3M
0% more funds holding in top 10
Funds holding in top 10: 4 [Q3] → 4 (+0) [Q4]
0.97% less ownership
Funds ownership: 101.8% [Q3] → 100.83% (-0.97%) [Q4]
2% less repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 124
6% less funds holding
Funds holding: 378 [Q3] → 355 (-23) [Q4]
16% less first-time investments, than exits
New positions opened: 76 | Existing positions closed: 91
32% less capital invested
Capital invested by funds: $5.57B [Q3] → $3.8B (-$1.77B) [Q4]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Mizuho Steven Valiquette 14% 1-year accuracy 1 / 7 met price target | 40%upside $18 | Neutral Maintained | 13 Mar 2025 |
Wells Fargo Vik Chopra 27% 1-year accuracy 3 / 11 met price target | 48%upside $19 | Equal-Weight Maintained | 28 Feb 2025 |
Barrington Research Michael Petusky 17% 1-year accuracy 12 / 70 met price target | 56%upside $20 | Outperform Maintained | 28 Feb 2025 |
Baird Jeffrey Johnson 0 / 0 met price target | 56%upside $20 | Neutral Maintained | 28 Feb 2025 |
Jefferies Glen Santangelo 45% 1-year accuracy 5 / 11 met price target | 56%upside $20 | Hold Downgraded | 23 Jan 2025 |
Financial journalist opinion
Based on 18 articles about XRAY published over the past 30 days









